SCOPUS 정보 검색 플랫폼

Volumn 17, Issue 2, 2010, Pages 407-415

Cytoreductive surgery in patients with metastatic gastrointestinal stromal tumor treated with sunitinib malate

(10) Raut, Chandrajit P a Wang, Qian a Manola, Judith a Morgan, Jeffrey A a George, Suzanne a Wagner, Andrew J a Butrynski, James E a Fletcher, Christopher D M a Demetri, George D a Bertagnolli, Monica M a

a BRIGHAM AND WOMEN S HOSPITAL (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; IFOSFAMIDE; IMATINIB; RAPAMYCIN; SUNITINIB; THALIDOMIDE; TRABECTEDIN;

ABDOMINAL ABSCESS; ABDOMINAL BLEEDING; ADJUVANT THERAPY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BILE LEAKAGE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CHYLOUS ASCITES; CLINICAL ARTICLE; COLON RESECTION; CYSTECTOMY; CYTOREDUCTIVE SURGERY; DIARRHEA; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; ENTEROCUTANEOUS FISTULA; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GASTRECTOMY; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL STROMAL TUMOR; HEART ATRIUM FIBRILLATION; HUMAN; HYSTERECTOMY; ILEUS; ILIAC VEIN INJURY; LIVER RESECTION; LUNG EMBOLISM; MALE; METASTASIS; OPEN ABDOMEN; OVERALL SURVIVAL; PANCREAS RESECTION; PERICARDIAL EFFUSION; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PROGNOSIS; PROGRESSION FREE SURVIVAL; RECTUM ABDOMINOPERINEAL RESECTION; REOPERATION; RETROSPECTIVE STUDY; SALPINGOOOPHORECTOMY; SEROMA; SMALL INTESTINE OBSTRUCTION; SMALL INTESTINE RESECTION; SPLENECTOMY; TRANSFUSION RELATED ACUTE LUNG INJURY; TREATMENT RESPONSE; WOUND; WOUND DEHISCENCE; WOUND INFECTION;

ADULT; AGED; ANTINEOPLASTIC AGENTS; FEASIBILITY STUDIES; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; INDOLES; MALE; MIDDLE AGED; PROTEIN-TYROSINE KINASES; PYRROLES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77149155973 PISSN: 10689265 EISSN: 15344681 Source Type: Journal
DOI: 10.1245/s10434-009-0784-y Document Type: Article

Times cited : (64)

References (12)

1
- 39149127634
- Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033
- DOI 10.1200/JCO.2007.13.4452
- CD Blanke C Rankin GD Demetri, et al. 2008 Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033 J Clin Oncol 26 626 632 10.1200/JCO.2007.13.4452 1:CAS:528:DC%2BD1cXis1alsLs%3D 18235122 (Pubitemid 351264358)
- (2008) Journal of Clinical Oncology , vol.26 , Issue.4 , pp. 626-632
- Blanke, C.D.¹ Rankin, C.² Demetri, G.D.³ Ryan, C.W.⁴ Von Mehren, M.⁵ Benjamin, R.S.⁶ Raymond, A.K.⁷ Bramwell, V.H.C.⁸ Baker, L.H.⁹ Maki, R.G.¹⁰ Tanaka, M.¹¹ Hecht, J.R.¹² Heinrich, M.C.¹³ Fletcher, C.D.M.¹⁴ Crowley, J.J.¹⁵ Borden, E.C.¹⁶

2
- 33845633389
- Surgical resection of gastrointestinal stromal tumors after treatment with imatinib
- DOI 10.1245/s10434-006-9034-8
- RH Andtbacka CS Ng CL Scaife, et al. 2007 Surgical resection of gastrointestinal stromal tumors after treatment with imatinib Ann Surg Oncol 14 14 24 10.1245/s10434-006-9034-8 17072676 (Pubitemid 44954266)
- (2007) Annals of Surgical Oncology , vol.14 , Issue.1 , pp. 14-24
- Andtbacka, R.H.I.¹ Ng, C.S.² Scaife, C.L.³ Cormier, J.N.⁴ Hunt, K.K.⁵ Pisters, P.W.T.⁶ Pollock, R.E.⁷ Benjamin, R.S.⁸ Burgess, M.A.⁹ Chen, L.L.¹⁰ Trent, J.¹¹ Patel, S.R.¹² Raymond, K.¹³ Feig, B.W.¹⁴

3
- 33845619526
- Impact of surgery on advanced gastrointestinal stromal tumors (GIST) in the imatinib era
- DOI 10.1245/s10434-006-9047-3
- S Bonvalot H Eldweny CL Pechoux, et al. 2006 Impact of surgery on advanced gastrointestinal stromal tumors (GIST) in the imatinib era Ann Surg Oncol 13 1596 1603 10.1245/s10434-006-9047-3 1:STN:280:DC%2BD28jhvVahtQ%3D%3D 16957966 (Pubitemid 44951467)
- (2006) Annals of Surgical Oncology , vol.13 , Issue.12 , pp. 1596-1603
- Bonvalot, S.¹ Eldweny, H.² Pechoux, C.L.³ Vanel, D.⁴ Terrier, P.⁵ Cavalcanti, A.⁶ Robert, C.⁷ Lassau, N.⁸ Cesne, A.L.⁹

4
- 34247610583
- Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor
- DOI 10.1097/01.sla.0000236630.93587.59, PII 0000065820070300000003
- RP DeMatteo RG Maki S Singer, et al. 2007 Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor Ann Surg 245 347 352 10.1097/01.sla.0000236630.93587.59 17435539 (Pubitemid 46673128)
- (2007) Annals of Surgery , vol.245 , Issue.3 , pp. 347-352
- DeMatteo, R.P.¹ Maki, R.G.² Singer, S.³ Gonen, M.⁴ Brennan, M.F.⁵ Antonescu, C.R.⁶

5
- 34247615184
- Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advanced/metastatic GIST
- DOI 10.1097/01.sla.0000242710.36384.1b, PII 0000065820070300000002
- A Gronchi M Fiore F Miselli, et al. 2007 Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advanced/metastatic GIST Ann Surg 245 341 346 10.1097/01.sla.0000242710.36384.1b 17435538 (Pubitemid 46673127)
- (2007) Annals of Surgery , vol.245 , Issue.3 , pp. 341-346
- Gronchi, A.¹ Fiore, M.² Miselli, F.³ Lagonigro, M.S.⁴ Coco, P.⁵ Messina, A.⁶ Pilotti, S.⁷ Casali, P.G.⁸

6
- 33744795769
- Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors
- DOI 10.1200/JCO.2005.05.3439
- CP Raut M Posner J Desai, et al. 2006 Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors J Clin Oncol 24 2325 2331 10.1200/JCO.2005.05.3439 1:CAS:528:DC%2BD28XlvV2ksbw%3D 16710031 (Pubitemid 46630664)
- (2006) Journal of Clinical Oncology , vol.24 , Issue.15 , pp. 2325-2331
- Raut, C.P.¹ Posner, M.² Desai, J.³ Morgan, J.A.⁴ George, S.⁵ Zahrieh, D.⁶ Fletcher, C.D.M.⁷ Demetri, G.D.⁸ Bertagnolli, M.M.⁹

7
- 33644667084
- Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate
- 10.1002/jso.20466 16496358
- P Rutkowski Z Nowecki P Nyckowski, et al. 2006 Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate J Surg Oncol 93 304 311 10.1002/jso.20466 16496358
- (2006) J Surg Oncol , vol.93 , pp. 304-311
- Rutkowski, P.¹ Nowecki, Z.² Nyckowski, P.³

8
- 33749505836
- Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: A randomised controlled trial
- DOI 10.1016/S0140-6736(06)69446-4, PII S0140673606694464
- GD Demetri AT van Oosterom CR Garrett, et al. 2006 Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial Lancet 368 1329 1338 10.1016/S0140-6736(06)69446-4 1:CAS:528:DC%2BD28XhtVOrtL%2FL 17046465 (Pubitemid 44528723)
- (2006) Lancet , vol.368 , Issue.9544 , pp. 1329-1338
- Demetri, G.D.¹ Van Oosterom, A.T.² Garrett, C.R.³ Blackstein, M.E.⁴ Shah, M.H.⁵ Verweij, J.⁶ McArthur, G.⁷ Judson, I.R.⁸ Heinrich, M.C.⁹ Morgan, J.A.¹⁰ Desai, J.¹¹ Fletcher, C.D.¹² George, S.¹³ Bello, C.L.¹⁴ Huang, X.¹⁵ Baum, C.M.¹⁶ Casali, P.G.¹⁷

9
- 0034594628
- New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
- 10.1093/jnci/92.3.205 1:STN:280:DC%2BD3c7it1Gitg%3D%3D 10655437
- P Therasse SG Arbuck EA Eisenhauer, et al. 2000 New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 205 216 10.1093/jnci/92.3.205 1:STN:280:DC%2BD3c7it1Gitg%3D%3D 10655437
- (2000) J Natl Cancer Inst , vol.92 , pp. 205-216
- Therasse, P.¹ Arbuck, S.G.² Eisenhauer, E.A.³

10
- 33845382806
- Nonparametric estimation from incomplete observations
- 10.2307/2281868
- EL Kaplan P Meier 1958 Nonparametric estimation from incomplete observations J Am Stat Assoc 53 457 481 10.2307/2281868
- (1958) J Am Stat Assoc , vol.53 , pp. 457-481
- Kaplan, E.L.¹ Meier, P.²

11
- 34047198463
- Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: The French sarcoma group
- DOI 10.1200/JCO.2006.09.0183
- JY Blay A Le Cesne I Ray-Coquard, et al. 2007 Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group J Clin Oncol 25 1107 1113 10.1200/JCO.2006.09.0183 1:CAS:528:DC%2BD2sXksVyrs7s%3D 17369574 (Pubitemid 46596763)
- (2007) Journal of Clinical Oncology , vol.25 , Issue.9 , pp. 1107-1113
- Blay, J.-Y.¹ Le Cesne, A.² Ray-Coquard, I.³ Bui, B.⁴ Duffaud, F.⁵ Delbaldo, C.⁶ Adenis, A.⁷ Viens, P.⁸ Rios, M.⁹ Bompas, E.¹⁰ Cupissol, D.¹¹ Guillemet, C.¹² Kerbrat, P.¹³ Fayette, J.¹⁴ Chabaud, S.¹⁵ Berthaud, P.¹⁶ Perol, D.¹⁷

12
- 39749107551
- Does interruption of imatinib (IM) in responding patients after three years of treatment influence outcome of patients with advanced GIST included in the BFR14 trial?
- 10.1200/JCO.2007.15.4849
- A Adenis PA Cassier BN Bui, et al. 2008 Does interruption of imatinib (IM) in responding patients after three years of treatment influence outcome of patients with advanced GIST included in the BFR14 trial? J Clin Oncol 26 A10522 10.1200/JCO.2007.15.4849
- (2008) J Clin Oncol , vol.26 , pp. 10522
- Adenis, A.¹ Cassier, P.A.² Bui, B.N.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.